Lung Cancer
Conditions
Keywords
lung cancer, caregiver
Brief summary
The purpose of this pilot study is to examine, in an innovative setting, the potential for a lung cancer diagnosis in a loved one to represent a teachable moment for smoking cessation in family members or caregivers who are current smokers. The researchers will identify the willingness and preferred modality for smoking cessation among family members/caregivers in this setting. The researchers will estimate abstinence rates at 4, 8, 12, and 24 weeks..
Interventions
BEHAVIORALDigital-based support
Digital support will consist of referral for the participant to visit https://smokefree.gov, a website which offers a menu of internet- and text-based support options.
BEHAVIORALTraditional-based support + Nicotine replacement therapy (NRT)
Traditional support will consist of participant referral to the Indiana Tobacco Quitline (1-800-QUIT-NOW) which is a telephone hotline that connects participants to Indiana smoking cessation resources.
Sponsors
Indiana University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Patient Inclusion Criteria: 1. patient with newly diagnosed lung cancer within the last 6 months of initial diagnosis/confirmation of diagnosis at the study sites 2. Able to provide informed consent 3. Able to speak and read English Family Member/Caregiver Participant Criteria: 1. Family member or caregiver (defined as first degree relative \[parent, sibling, child\] or person living in the same household) 2. Family member or caregiver must be a current, active smoker (defined as 10 cigarettes per day for 6 consecutive months). 3. At least 18 years of age at time of study consent 4. Able to provide informed consent 5. Able to speak and read English
Exclusion criteria
1. Currently receiving formal tobacco dependence treatment- Nicotine replacement of any kind, varenicycline or Bupropion. 2. Medical condition that precludes proposed pharmacotherapy for smoking cessation : Recent (≤ 2 weeks) myocardial infarction , history of underlying arrhythmias , history of serious or worsening angina pectoris, pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 7-day point prevalence of self -reported smoking cessation | 4 weeks | — |
| Willingness to quit | 4 weeks | — |
| Preference for type of cessation intervention modality | 4 weeks | digital versus traditional support with nicotine replacement therapy \[NRT\] |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mean change in readiness to quit | Baseline | Measured via the Readiness to Quit Ladder |
| Mean change in nicotine dependence | Baseline | Measured via the Heaviness of Smoking Index |
| Mean change in cigarette use | Baseline | Measured by by the self-reported number of cigarettes smoked per day |
Countries
United States
Outcome results
None listed